| Evans B and Griner E |
Registered report: Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. |
2015 |
Elife |
pmid:26231040
|
| Wu F et al. |
Inhibition of Cancer-Associated Mutant Isocitrate Dehydrogenases by 2-Thiohydantoin Compounds. |
2015 |
J. Med. Chem. |
pmid:26280302
|
| Li L et al. |
Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondrosarcoma Cells. |
2015 |
PLoS ONE |
pmid:26368816
|
| Nadtochiy SM et al. |
Metabolomic profiling of the heart during acute ischemic preconditioning reveals a role for SIRT1 in rapid cardioprotective metabolic adaptation. |
2015 |
J. Mol. Cell. Cardiol. |
pmid:26388263
|
| Cheng QY et al. |
Sensitive Determination of Onco-metabolites of D- and L-2-hydroxyglutarate Enantiomers by Chiral Derivatization Combined with Liquid Chromatography/Mass Spectrometry Analysis. |
2015 |
Sci Rep |
pmid:26458332
|
| Andronesi OC et al. |
Treatment Response Assessment in IDH-Mutant Glioma Patients by Noninvasive 3D Functional Spectroscopic Mapping of 2-Hydroxyglutarate. |
2016 |
Clin. Cancer Res. |
pmid:26534967
|
|
|
|
|
pmid:26582645
|
| Liesenfeld DB et al. |
Aspirin Reduces Plasma Concentrations of the Oncometabolite 2-Hydroxyglutarate: Results of a Randomized, Double-Blind, Crossover Trial. |
2016 |
Cancer Epidemiol. Biomarkers Prev. |
pmid:26585118
|
| Li F et al. |
NADP(+)-IDH Mutations Promote Hypersuccinylation that Impairs Mitochondria Respiration and Induces Apoptosis Resistance. |
2015 |
Mol. Cell |
pmid:26585387
|
| Churchill H et al. |
Discordant intracellular and plasma D-2-hydroxyglutarate levels in a patient with IDH2 mutated angioimmunoblastic T-cell lymphoma. |
2015 |
Int J Clin Exp Pathol |
pmid:26617922
|
| Emir UE et al. |
Noninvasive Quantification of 2-Hydroxyglutarate in Human Gliomas with IDH1 and IDH2 Mutations. |
2016 |
Cancer Res. |
pmid:26669865
|
| Tateishi K et al. |
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ Depletion. |
2015 |
Cancer Cell |
pmid:26678339
|
| Wang P et al. |
Oncometabolite D-2-Hydroxyglutarate Inhibits ALKBH DNA Repair Enzymes and Sensitizes IDH Mutant Cells to Alkylating Agents. |
2015 |
Cell Rep |
pmid:26686626
|
| de la Fuente MI et al. |
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma. |
2016 |
Neuro-oncology |
pmid:26691210
|
| Flavahan WA et al. |
Insulator dysfunction and oncogene activation in IDH mutant gliomas. |
2016 |
Nature |
pmid:26700815
|
| Becker-Kettern J et al. |
Saccharomyces cerevisiae Forms D-2-Hydroxyglutarate and Couples Its Degradation to D-Lactate Formation via a Cytosolic Transhydrogenase. |
2016 |
J. Biol. Chem. |
pmid:26774271
|
| Heo H et al. |
On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel. |
2016 |
PLoS ONE |
pmid:26820720
|
| Fathi AT et al. |
Elevation of Urinary 2-Hydroxyglutarate in IDH-Mutant Glioma. |
2016 |
Oncologist |
pmid:26834160
|
| Fiehn O et al. |
Registered report: The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. |
2016 |
Elife |
pmid:26943899
|
|
|
|
|
pmid:26945443
|
|
|
|
|
pmid:26970248
|
|
|
|
|
pmid:26991680
|
|
|
|
|
pmid:27005468
|
| Chaturvedi A et al. |
Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate. |
2016 |
Leukemia |
pmid:27063596
|
|
|
|
|
pmid:27131892
|
| Nagashima H et al. |
Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma. |
2016 |
Neuro-oncology |
pmid:27154922
|
|
|
|
|
pmid:27234847
|
|
|
|
|
pmid:27295961
|
| Teng X et al. |
Lactate Dehydrogenase C Produces S-2-Hydroxyglutarate in Mouse Testis. |
2016 |
ACS Chem. Biol. |
pmid:27333189
|
|
|
|
|
pmid:27340277
|
| Ricoult SJ et al. |
Sterol Regulatory Element Binding Protein Regulates the Expression and Metabolic Functions of Wild-Type and Oncogenic IDH1. |
2016 |
Mol. Cell. Biol. |
pmid:27354064
|
| Fujii T et al. |
Targeting isocitrate dehydrogenase (IDH) in cancer. |
2016 |
Discov Med |
pmid:27355333
|
|
|
|
|
pmid:27380194
|
| Jafari-Khouzani K et al. |
Volumetric relationship between 2-hydroxyglutarate and FLAIR hyperintensity has potential implications for radiotherapy planning of mutant IDH glioma patients. |
2016 |
Neuro-oncology |
pmid:27382115
|
|
|
|
|
pmid:27406240
|
|
|
|
|
pmid:27419250
|
| Kingsbury JM et al. |
Cancer-associated isocitrate dehydrogenase mutations induce mitochondrial DNA instability. |
2016 |
Hum. Mol. Genet. |
pmid:27427385
|
| Johannessen TA et al. |
Rapid Conversion of Mutant IDH1 from Driver to Passenger in a Model of Human Gliomagenesis. |
2016 |
Mol. Cancer Res. |
pmid:27430238
|
|
|
|
|
pmid:27454352
|
|
|
|
|
pmid:27460417
|
|
|
|
|
pmid:27469509
|
|
|
|
|
pmid:27507897
|
| Nadtochiy SM et al. |
Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling. |
2016 |
J. Biol. Chem. |
pmid:27510037
|
|
|
|
|
pmid:27543339
|
|
|
|
|
pmid:27582470
|
| Kim H et al. |
In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists. |
2016 Sep-Oct |
Korean J Radiol |
pmid:27587950
|
| Tyrakis PA et al. |
S-2-hydroxyglutarate regulates CD8+ T-lymphocyte fate. |
2016 |
Nature |
pmid:27798602
|
|
|
|
|
pmid:27806325
|
| Burr SP et al. |
Mitochondrial Protein Lipoylation and the 2-Oxoglutarate Dehydrogenase Complex Controls HIF1α Stability in Aerobic Conditions. |
2016 |
Cell Metab. |
pmid:27923773
|
|
|
|
|
pmid:27956631
|
